The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions

Bo Young Nam1, Jisun Paeng, Seung Hye Kim

  • 1Department of Internal Medicine, College of Medicine, Severance Biomedical Science Institute, Yonsei University, Seodaemoon-Gu, Seoul, Korea.

Insights

The MCP-1/CCR2 system and TGF-β1 contribute to podocyte apoptosis in diabetic nephropathy. Inhibiting CCR2 reduces high glucose-induced cell death and TGF-β1 levels, suggesting a therapeutic target.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Diabetic nephropathy involves inflammation, with monocyte chemoattractant protein-1 (MCP-1) playing a key role.
  • The direct impact of the MCP-1/CCR2 system on podocyte apoptosis in diabetes remains unclear.

Purpose of the Study:

  • To investigate the role of the MCP-1/CCR2 system in high glucose-induced podocyte apoptosis.
  • To explore the interplay between MCP-1/CCR2 and TGF-β1 in diabetic kidney disease.

Main Methods:

  • In vitro studies using mouse podocytes exposed to high glucose, MCP-1, or TGF-β1, with CCR2 inhibition (siRNA or RS102895).
  • In vivo studies using db/m and db/db mice treated with RS102895.
  • Western blot and TUNEL staining to assess apoptosis and cleaved caspase-3 expression.

Main Results:

  • CCR2 inhibition significantly reduced high glucose-induced podocyte apoptosis and TGF-β1 levels.
  • MCP-1 directly induced apoptosis via CCR2; TGF-β1-induced apoptosis was also ameliorated by CCR2 inhibition.
  • db/db mice showed increased glomerular apoptosis, which was attenuated by RS102895 treatment.

Conclusions:

  • The MCP-1/CCR2 system, in conjunction with TGF-β1, contributes to podocyte apoptosis in diabetic conditions.
  • Targeting the MCP-1/CCR2 pathway may offer a therapeutic strategy for diabetic nephropathy.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.